A critical breakthrough in cancer investigation is occurring with the use of nanobodies to re-engage mutated p53. This essential tumor suppressor protein is frequently disabled in several types of malignancies, causing https://nybookmark.com/story23915631/mini-antibodies-restore-the-p53-protein-a-promising-pathway-for-malignant-therapy